Use of UVA1 in the treatment of mycosis fungoides - Case report

Postepy Dermatologii i Alergologii

Volumn 28, Issue 2, 2011, Pages 157-163

  Olek Hrab, Karolina ^a   Osmola Mańkowska, Agnieszka ^a   Silny, Wojciech ^a   Bowszyc Dmochowska, Monika ^a   Dańczak Pazdrowska, Aleksandra ^a   Sadowska, Anna ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Mycosis fungoides; Primary cutaneous T cell lymphomas; Ultrasonography; UVA1

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; DRUG DOSE REDUCTION; EPILEPSY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MYCOSIS FUNGOIDES; PHOTOTHERAPY; PSORIASIS VULGARIS; RADIATION DOSE; TOTAL SKIN ELECTRON THERAPY; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET A1 RADIATION;

EID: 79955584664     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alibert JL. Description des maladies de la peau observes a l'hospital St Louis. Barrois L'Aine et Fils 1806; 413-46.
2. Bazin PA. Maladies de la peau observes a l'hospital St Louis. 1876.
3. Sézary A, Bouvrain Y. Erytroderme avec pesence de cellules monstruenses dans le derme et le sang circulant. Bull Soc Fr Dermatol Sypholigr 1938; 45: 254-60.
4. Willemze R. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85. (Pubitemid 40656118)
5. Smith BD, Wilson LD. Cutaneous lymphoma. Curr Probl Cancer 2008; 32: 43-87. (Pubitemid 351320581)
6. Massone C, Kodama K, Kerl H, Cerroni L. Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol 2005; 29: 550-60. (Pubitemid 40411190)
7. Elmer KB, George RM. Cutaneous T-cell lymphoma presenting as benign dermatoses. Am Fam Phisician 1999; 59: 2809-13. (Pubitemid 29239264)
8. Jankowska-Konsur A, Maj J, Woźniak Z, et al. Ocena angiogenezy u chorych na ziarniniaka grzybiastego. Post Dermatol Alergol 2009; XXVI: 186-9.
9. th ed. J.B. Lippincott Company, Philadelphia 1990.
10. Sokołowska-Wojdyło M, Lech-Mareńda E, Placek W, et al. Leczenie pierwotnych chłoniaków skóry - rekomendacje Sekcji Chłoniaków Skóry Polskiej Grupy Badawczej Chłoniaków (PLRG). Onkol Prakt Klin 2010; 6: 29-47.
11. Whittemore AS, Holly EA, Lee IM, et al. Mycosis fungoides in relation to environment al exposures and immune response: a case-control study. J Natl Cancer Inst 1989; 81: 1560-7. (Pubitemid 19253304)
12. Hall WW, Liu CR, Schneewind O, et al. Deleted HTLV-1 provirusin blond and cutaneous lesions of patients with mycosis fungoides. Science 1991; 253: 317-20. (Pubitemid 21917157)
13. Wood GS, Salvekar A, Schaffer J, et al. Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-1) in the pathogenesis of American cutaneous T-cell lymphoma. J Invest Dermatol 1996; 107: 301-7. (Pubitemid 26284333)
14. Zackheim HS. Cutaneous T cell lymphoma: update of treatment. Dermatology 1999; 199: 102-5. (Pubitemid 29494782)
15. Gruss C, Strucker M, Kobyletzki G, et al. Low dose UVA1 phototherapy in disabling pansclerotic morphoea in childhood. Br J Dermatol 1997; 136: 293-4. (Pubitemid 27062748)
16. Godar DE. UVA1 radiation mediates singlet-oxygen and superoxide anion production rich trigger two different final apoptotic pathways: the S and P site of mitochondria. J Invest Dermatol 1999; 112: 3-12.
17. Silny W, Osmola-Mańkowska A, Czarnecka-Opreacz M, et al. Wa̧skopasmowa fototerapia UVA1 w lecznictwie dermatologicznym - pierwsze polskie doniesienie. Post Dermatol Alergol 2010; XXVII: 1-10.
18. Plattenberg H, Stege H, Megahed M, et al. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999; 41: 47-50. (Pubitemid 29336852)
19. Zane C, Leali C, Airo P, et al. High-dose UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001; 44: 629-33. (Pubitemid 32249520)
20. Gniadecki R, Assaf C, Bagot M, et al. The optimal use of bexarotene in cutaneous T-cell lymphoma. Br J Dermatol 2007; 157: 433-40. (Pubitemid 47256108)
21. Duvic M. Systemic monotherapy vs combination therapy for CTCL: rationale and future strategies. Oncology 2007; 21 (2 Suppl 1): 33-40.
22. Batycka-Baran A, Reich A, Jankowska-Konsur A, Maj J. Nowe trendy w leczeniu ziarniniaka grzybiastego i zespołu Sezarego. Post Dermatol Alergol 2009; XXVI: 41-55.